Source: Annual Congress 2010 - Oncological problems, surgical risk and complications
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
S. Alsayed, E. Mousa (Jeddah, Saudi Arabia). The value of biochemical parameters of the pleural aspirate in predicting success of chemical pleurodesis in malignant pleural effusion. Eur Respir J 2010; 36: Suppl. 54, 2778

Member's Comments

No comment yet.

Related content which might interest you: Utility of pleural fluid for predictive marker testing in malignant pleural effusion Source: Virtual Congress 2020 – Malignant pleural effusion in 2020: understanding the biology and clinical implications Year: 2020 Correlation between pleural fluid cytological yield and pleural tumour burden in malignant pleural effusions Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement? Year: 2010 Day case rapid pleurodesis in malignant pleural effusion Source: Virtual Congress 2021 – Novelties in interventional pulmonology Year: 2021 The value of thoracoscopy in malignant pleural effusions Source: Eur Respir J 2001; 18: Suppl. 33, 516s Year: 2001 Thoracoscopic evaluation of the effect of tumour burden on the outcome of pleurodesis in malignant pleural effusion Source: Virtual Congress 2021 – Pleural disease and bronchoscopic lung volume reduction Year: 2021 Predictors of successful pleurodesis for patients with malignant pleural effusions Source: Eur Respir J 2004; 24: Suppl. 48, 493s Year: 2004 The profile of neutrophils and D-dimer in pleural fluid is useful to monitor the pleurodesis process after talc poudrage in malignant pleural effusions (MPE) Source: Eur Respir J 2002; 20: Suppl. 38, 70s Year: 2002 Cytology of pleural fluid versus histopathology of the pleura in the diagnosis of malignant pleural effusions Source: Eur Respir J 2006; 28: Suppl. 50, 775s Year: 2006 The Abrams pleural biopsy is still useful in the diagnosis of pleural effusions Source: Annual Congress 2009 - Pleural diseases Year: 2009 Closed pleural needle biopsy and pleural fluid examination in pathological diagnosis of malignant pleural effusion Source: Eur Respir J 2003; 22: Suppl. 45, 256s Year: 2003 Optimal treatment of pleurodesis for malignant pleural effusion in 2017 Source: ERS Skills course - Medical thoracoscopy Year: 2017 Pleurodesis for malignant pleural effusion Source: ERS Course 2016 - Skills course on medical thoracoscopy Year: 2016 Pleurodesis for malignant pleural effusion Source: School Course 2014 - Medical Thoracoscopy Year: 2014 Pleurodesis in the treatment of malignant pleural effusion Source: Eur Respir J 2004; 24: Suppl. 48, 628s Year: 2004 Is ²blind² pleural biopsy still of value in tuberculous effusions? Source: Annual Congress 2008 - Diagnosis of tuberculosis: problems and perspectives Year: 2008 Critical issues in pleural fluid examinations: laboratory parameters, tumour markers and cytological methods Source: ISSN=1025-448x, ISBN=1-904097-25-1, page=110 Year: 2002 Chemical pleurodesis for malignant pleural effusion: a comparative study Source: Eur Respir J 2006; 28: Suppl. 50, 51s Year: 2006 Accuracy of pleural fluid c-reactive protein in differentiating between tuberculous and malignant pleural effusions: a meta-analysis Source: International Congress 2019 – Tuberculosis and comorbidities Year: 2019 Pleural fluid DNA integrity index as a diagnostic marker of malignant pleural effusion Source: International Congress 2017 – Mesothelioma and malignant pleural disease Year: 2017 Utility of closed pleural biopsy in the diagnosis of pleural effusions Source: Eur Respir J 2006; 28: Suppl. 50, 611s Year: 2006